ABVC BioPharma, Inc. (ABVC)
0.8254
-0.03
(-3.74%)
USD |
NASDAQ |
Sep 01, 16:00
0.83
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Research and Development Expense (Annual) : 0.1211M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.1211M |
| December 31, 2024 | 0.1793M |
| December 31, 2023 | 1.063M |
| December 31, 2022 | 2.694M |
| December 31, 2021 | 1.004M |
| December 31, 2020 | 0.5497M |
| December 31, 2019 | 1.049M |
| December 31, 2018 | 0.9887M |
| December 31, 2017 | 3.172M |
| September 30, 2016 | 10.00M |
| September 30, 2015 |
| Date | Value |
|---|---|
| September 30, 2014 | 0.00 |
| September 30, 2013 | |
| September 30, 2012 | |
| September 30, 2011 | 0.00 |
| September 30, 2010 | 0.00 |
| September 30, 2009 | 0.00 |
| September 30, 2008 | 0.00 |
| September 30, 2007 | 0.00 |
| September 30, 2006 | 0.00 |
| September 30, 2005 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Anika Therapeutics, Inc. | 25.77M |
| Perspective Therapeutics, Inc. | 70.96M |
| MiMedx Group, Inc. | 14.70M |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |